Altitude Life Science Ventures focuses on investing in early-stage life science companies with significant growth potential. They typically participate in Series A, B, and C rounds, with investments ranging across various stages of company development. Their investment strategy is centered on backing high-quality teams to build strong, defensible, and long-term businesses within the life sciences sector.
Notable portfolio companies include Beam Therapeutics, Generate Biomedicines, and Vir Biotechnology. The firm is led by experienced partners who bring a wealth of industry knowledge and connections to the table. Altitude Life Science Ventures offers unique value-add services to their portfolio companies, leveraging their deep expertise and network to support business growth and innovation.
Altitude Life Science Ventures - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Total Investments23
Current Portfolio Count13
Total Portfolio Exits2
Top Investment Stages
Series A7 (31.8%)
Series B6 (27.3%)
Series C6 (27.3%)
Series Unknown2 (9.1%)
Post Ipo Equity1 (4.5%)
Stage Mix
Series A 32%Series B 27%Series C 27%Series Unknown 9%Post Ipo Equity 5%
Concentration shown as share of disclosed investments by stage.
Altitude Life Science Ventures - Classification
- NAICS
- 520000Finance and Insurance
- 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
- 523900Other Financial Investment Activities
- 523990All Other Financial Investment Activities
- 523999Miscellaneous Financial Investment Activities
- SIC
- 6700Holding And Other Investment Offices
- 6790Miscellaneous Investing
- 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
- NAICS
- 525000Funds, Trusts, and Other Financial Vehicles
- 523910Miscellaneous Intermediation
- 523940Portfolio Management and Investment Advice
- SIC
- 6000Depository Institutions
- 6720Investment Offices
- 6722Management Investment Offices, Open-end